These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 7093267)

  • 1. Red blood cell [14C]cholesterol exchange and plasma cholesterol esterifying activity of normal and sickle cell blood.
    Jain SK; Shohet SB
    Biochim Biophys Acta; 1982 May; 688(1):11-5. PubMed ID: 7093267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane components in the red cells of patients with sickle cell anemia. Relationship to cell aging and to irreversibility of sickling.
    Westerman MP; Diloy-Puray M; Streczyn M
    Biochim Biophys Acta; 1979 Oct; 557(1):149-55. PubMed ID: 549632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrocyte membrane lipid reorganization during the sickling process.
    Chiu D; Lubin B; Shohet SB
    Br J Haematol; 1979 Feb; 41(2):223-34. PubMed ID: 427032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red cell membrane lipid dynamics.
    Lubin B; Kuypers F; Chiu D
    Prog Clin Biol Res; 1989; 319():507-22; discussion 523-4. PubMed ID: 2695937
    [No Abstract]   [Full Text] [Related]  

  • 5. Band 3 and glycophorin are progressively aggregated in density-fractionated sickle and normal red blood cells. Evidence from rotational and lateral mobility studies.
    Corbett JD; Golan DE
    J Clin Invest; 1993 Jan; 91(1):208-17. PubMed ID: 8423219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced erythrocyte membrane protein methylation in sickle cell anemia.
    Ro JY; Neilan B; Magee PN; Paik WK; Kim S
    J Biol Chem; 1981 Oct; 256(20):10572-6. PubMed ID: 7287725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of red cell membrane organization in sickle cell anaemia.
    Choe HR; Schlegel RA; Rubin E; Williamson P; Westerman MP
    Br J Haematol; 1986 Aug; 63(4):761-73. PubMed ID: 3730297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal membrane phospholipid asymmetry in sickle erythrocytes and its pathophysiologic significance.
    Lubin B; Chiu D; Roelofsen B; Van Deenen LL
    Prog Clin Biol Res; 1981; 56():171-93. PubMed ID: 7330009
    [No Abstract]   [Full Text] [Related]  

  • 9. Phospholipid composition of blood plasma, erythrocytes, and "ghosts" in sickle cell disease.
    Schwarz HP; Dahlke MB; Dreisbach L
    Clin Chem; 1977 Sep; 23(9):1548-50. PubMed ID: 890897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma and red cell lipids in sickle cell disease.
    Akinyanju PA; Akinyanju CO
    Ann Clin Lab Sci; 1976; 6(6):521-4. PubMed ID: 999221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmembrane mobility of phospholipids in sickle erythrocytes: effect of deoxygenation on diffusion and asymmetry.
    Blumenfeld N; Zachowski A; Galacteros F; Beuzard Y; Devaux PF
    Blood; 1991 Feb; 77(4):849-54. PubMed ID: 1993223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane phospholipid abnormalities in pathologic erythrocytes: a model for cell aging.
    Wagner G; Chiu DT; Schwartz RS; Lubin B
    Prog Clin Biol Res; 1985; 195():237-50. PubMed ID: 4059270
    [No Abstract]   [Full Text] [Related]  

  • 13. Factors influencing the lipid composition and fluidity of red cell membranes in vitro: production of red cells possessing more than two cholesterols per phospholipid.
    Cooper RA; Leslie MH; Fischkoff S; Shinitzky M; Shattil SJ
    Biochemistry; 1978 Jan; 17(2):327-31. PubMed ID: 619993
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in membrane polypeptides, polyphosphoinositides and phosphatidate in dense fractions of sickle cells.
    Raval PJ; Allan D
    Biochim Biophys Acta; 1986 Apr; 856(3):595-601. PubMed ID: 3008837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altering erythrocyte membrane composition with phospholipid exchange protein.
    Muczynski KA; Harris WE; Stahl WL
    Int J Biochem; 1981; 13(8):959-62. PubMed ID: 7274541
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell-bound autologous immunoglobulin in erythrocyte subpopulations from patients with sickle cell disease.
    Green GA; Rehn MM; Kalra VK
    Blood; 1985 May; 65(5):1127-33. PubMed ID: 3888304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel phospholipid in irreversibly sickled cells: evidence for in vivo peroxidative membrane damage in sickle cell disease.
    Jain SK; Shohet SB
    Blood; 1984 Feb; 63(2):362-7. PubMed ID: 6692040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities in membrane phospholipid organization in sickled erythrocytes.
    Lubin B; Chiu D; Bastacky J; Roelofsen B; Van Deenen LL
    J Clin Invest; 1981 Jun; 67(6):1643-9. PubMed ID: 7240412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocyte membrane vesicles and irreversibly sickled cells bind protein S.
    Lane PA; O'Connell JL; Marlar RA
    Am J Hematol; 1994 Dec; 47(4):295-300. PubMed ID: 7977302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane phospholipid organization in pathologic human erythrocytes.
    Lubin B; Chiu D
    Prog Clin Biol Res; 1982; 97():137-50. PubMed ID: 7156165
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.